Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 63 People Treated

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Feb 10, 2024 10:23am

165 Views

Post# 35873711

RE:RE:63 People Treated

That is right.

Since 37 patients treated before the end of the year seems ambitious considering enrollment to this point my question is this - what is the reason for that optimism?

Dr. Jewett going out and spreading the word will obviously help as will BTD, are the two linked? Timewise that is.